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ABSTRACT: Alzheimer’s disease (AD) is one of the most common forms of dementia
affecting millions of people worldwide. Currently, an easy and effective form of diagnosis is
missing, which significantly hinders a possible improvement of the patient’s quality of life.
In this context, biosensors emerge as a future solution, opening the doors for preventive
medicine and allowing the premature diagnosis of numerous pathologies. This work
presents a pioneering biosensor that combines a bottom-up design approach using paper as
a platform for the electrochemical recognition of peptide amyloid β-42 (Aβ-42), a
biomarker for AD present in blood, associated with visible differences in the brain tissue
and responsible for the formation of senile plaques. The sensor layer relies on a
molecularly imprinted polymer as a biorecognition element, created on the carbon ink electrode’s surface by electropolymerizing a
mixture of the target analyte (Aβ-42) and a monomer (O-phenylenediamine) at neutral pH 7.2. Next, the template molecule was
removed from the polymeric network by enzymatic and acidic treatments. The vacant sites so obtained preserved the shape of the
imprinted protein and were able to rebind the target analyte. Morphological and chemical analyses were performed in order to
control the surface modification of the materials. The analytical performance of the biosensor was evaluated by an electroanalytical
technique, namely, square wave voltammetry. For this purpose, the analytical response of the biosensor was tested with standard
solutions ranging from 0.1 ng/mL to 1 μg/mL of Aβ-42. The linear response of the biosensor went down to 0.1 ng/mL. Overall, the
developed biosensor offered numerous benefits, such as simplicity, low cost, reproducibility, fast response, and repeatability less than
10%. All together, these features may have a strong impact in the early detection of AD.
1. INTRODUCTION
Alzheimer’s disease (AD) is the most common form of
dementia, with 60−80% cases of dementia being attributed to
AD and affecting over 45 million people worldwide.1−3 This
neurodegenerative disease is characterized by forgetfulness that
evolves into memory loss, behavioral disturbances, and
numerous neuropsychiatric episodes.4 AD is currently
uncurable, and its early diagnosis is the best option for a
patient, although it is difficult, considering the lack of accurate
and effective tests that rely mostly on invasive clinical
examination.5,6
Recent studies have suggested that AD has systemic signs
caused by molecular changes within the disease progression,
acting as potential biomarkers. These includes amyloid-β or its
derivative compounds,7 tau/phosphorylated tau protein,8
BACE1 enzyme,9 and antibodies,10 among others. Among
these, the relevance of Aβ-42 for AD diagnosis is not
questionable, which may be used in isolated form when in
cerebrospinal fluid (CSF) or as a ratio when in evaluated
serum samples.7 AD biomarkers can be found in the blood and
CSF11 and until now were detected by complex and expensive
techniques such as enzyme-linked immunosorbent assays,12,13
in vivo positron emission tomography, mass spectrometry,
high-performance liquid chromatography,14 surface plasma
resonance,15−17 field effect transistors,18 and others.19 Most of
these forms of diagnostics only take in consideration the
detection in CSF, which makes them invasive, and some do
not allow a point-of-care (POC) analysis.20 A biosensor that
could detect an AD biomarker in blood or urine samples could
allow portability, reduction of cost, and an overall easier way to
diagnose the disease. In general, a biosensing device integrates
a biorecognition element immobilized in a support material,
and the interaction between the recognition layer and the
target analyte could be transduced by an electrochemical
signal.
Electrochemical biosensors show a fast and real-time
response, easier miniaturization, portability, low cost, simple
procedures, and a wide linear range of detection through the
combination of the conventional molecular methods, selectiv-
ity, and sensibility related to the signal transduction.21 Recent
developments in the literature report electrochemical bio-
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sensors for Aβ-42 using enzymes,22,23 peptides,24,25 pro-
teases,26 and mostly antibodies27−29 for CSF and serum
samples. All these elements, and antibodies in particular, show
limited stability and high cost.30 Overall, these handicaps may
be eliminated by replacing natural antibodies by synthetic
materials that are designed under close-to-native environment
conditions and/or reveal great affinity for the molecule of
interest. The synthetic solution to mimic natural antibodies
relies on using inexpensive polymeric materials, which allow
the same required selective recognition, while showing longer
stability, which reflects on the shelf life of the devices. Plastic
antibodies rely on molecularly imprinted polymer (MIP)
technology. MIP materials consist of a three- or two-
dimensional (3D or 2D) imprint of a target molecule in a
rigid polymeric matrix built with synthetic or natural
monomers. The template molecule is later removed without
disturbing the geometry of the solid matrix. The exclusion of
the target from the polymerized matrix generates imprinted
sites that match the size and shape of the target.31 These
imprinted sites are expected to act similar to natural antibodies,
rebinding to the target with great affinity and selectivity.31,32
Considering that the MIP will be integrated in an
electrochemical sensor, the suitable approach for polymer
growth is electropolymerization because it allows controlling
the film thickness and its morphology.33,34 In this, the template
particles and the monomers are mixed in the same solution and
create the polymeric matrix directly on the sensor surface when
the required electrical conditions are applied, making
biomolecule immobilization and MIP synthesis a one-step
process.35
There are currently few electrochemical biosensors with
MIP materials for AD. Table 1 lists the features of the already
developed electrochemical AD biosensors with Aβ-42 as the
biomarker. Moreira and Sales36 in their first MIP-based sensor
for AD have achieved a limit of detection (LOD) of 0.20 ng/
mL, which was surpassed in their second work,4 in which they
accomplished an LOD value in the pg/mL range (0.40 pg/
mL) without the need to incubate an active redox element on
the working electrode (WE). Their monomer of choice was
aniline, for being stable and easily electropolymerized, much
alike phenylenediamine. Emam et al.37 opted for pyrrole,
whose electropolymerization conditions are well studied
because their MIP-based sensor was very innovative by
diagnosing AD in a noninvasive method through the breath
of the patient. It is important to highlight that the previously
described MIP biosensors, devoted to Aβ-42, may be
developed to target other biomarkers circulating in the
blood, including Aβ-42 derivatives, most recently established
as highly significant in terms of AD.7 Overall, considering the
increasing worldwide incidence of AD, a suitable inexpensive
and eco-friendly biosensor with high stability and selectivity is
still missing.
The ever-increasing healthcare costs together with the
consumer demand, lack of medical care in poor-resource
countries, and the constant need for renewable materials are
enough reasons to create a new generation of inexpensive,
disposable, and less-invasive sensors amenable to mass
production to provide the maintenance of welfare, early
diagnostics, and medical prevention. These sensors will use low
cost and/or flexible materials, such as poly(ethylene tereph-
thalate),38 print-circuit board,39 glass, and paper.40 Among
these, paper is easy to fabricate and mass-producible. It has a
significantly lower price than plastic substrates, is disposable,
and also presents the advantage of being recyclable, while
being made from reusable raw materials.41 So, it makes sense
to develop an easy-to-use, rapid, and inexpensive POC device
with this substrate.42,43
Promising reports of electronic devices fabricated directly
onto paper substrates have been recently published.44,45 Paper
has a porous structure and a large surface roughness. It can
show fibers with different sizes and shapes, depending on their
origin and treatments,46 but suitable printing schemes enable
their easy modification.47,48 Currently, the few published works
that combine plastic antibodies with the electrochemical
detection of Aβ-42 have chosen rigid substrates such as glass
and ceramic, and therefore this work aims to be the first one to
apply this technology on a flexible paper platform.
Plenty of conductive materials can work as electrodes, but
the most commonly used is carbon. Carbon comes in
numerous varieties of forms and has an extensive application
in electrochemical studies. When compared with metal
electrodes, carbon has many advantages because of its low
cost, wide range of potential windows, and high chemical
stability.49−51 Carbon’s most common form is based on the
graphite structure, which can be modified or enhanced by
surface treatments and modifications and can increase surface
roughness, surface area, or oxygenated functional groups on
the electrode surface.
The present work describes for the first time a MIP-based
electrochemical biosensor for the early diagnosis of AD in a
paper-based platform. The biomimetic material consists of a
polymeric matrix generated by the electropolymerization of the
monomer O-phenylenediamine (OPDA) in the presence of the
chosen biomarker. To evaluate the success of Aβ-42
imprinting, the electrochemical response of the created devices
is compared with nonimprinted polymeric (NIP) materials,
which were made in the absence of a template during the
electropolymerization step.
2. RESULTS AND DISCUSSION
2.1. Electrodes Pretreatment. A first study was
performed to select a suitable pretreatment or cleaning process
that would improve the conductivity properties of the carbon
electrodes, which presented an initial sheet resistance of 25.69
Ω/square. Readings in blank conditions were done to confirm
similarity between several samples. Cyclic voltammetry (CV)
and electrochemical impedance spectroscopy (EIS) data
(Figure S1) showed the existence of negligible differences.
Table 1. MIP-Based Electrochemical Biosensors for Aβ-42 Detectiona
substrate monomer technique sample LOD year refs
Au-WE on ceramic aniline EIS/SWV FBS 420.25 ng/mL (EIS); 0.20 ng/mL (SWV) 2017 36
graphene on GC pyrrole CV breath 0.02 Ppb 2018 37
C-SPE on ceramic aniline SWV cormay Serum 0.40 pg/mL 2018 4
aAu-WE: gold WE; C-SPE: carbon screen-printed electrode; GC: glassy carbon; CV: cyclic voltammetry; SWV: square-wave voltammetry; FBS:
fetal bovine serum.
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Nonetheless, similar carbon ink homemade electrodes (CI-
HMEs) were chosen, and a pretreatment procedure that could
work for all was implemented.
In order to get better electrical features, 3,4-3,4-ethyl-
enedioxythiophene (EDOT) modification was selected as the
pretreatment stage for CI-HMEs. Such pretreatment stage
improved the activity of the electrode by adding a highly
conductive polymer layer to the carbon support and by
increasing the roughness and number of reactive sites on the
electrode surface. For this purpose, the electrodes were treated
by chronoamperometry with an EDOT solution for 10 s at 1 V.
This potential was selected in agreement with Cardoso et al.35
ensuring that the oxidation potential of EDOT was reached on
this surface and that it was not overpassed, which could lead to
decomposition of the conductive film.52 The time for applying
this potential followed the studies made in another carbon
support tested, as shown in Figure S2.
The improvement of the electrical features is clearly shown
in Figure S3. Overall, before pretreatment, no oxidation and
reduction peaks were observed within the range of potential
applied. This behavior is attributed to the irreversibility of the
electrochemical process and the consequent slow rate of the
electron charge transfer on the electrode surface.
After poly(3,4-ethylenedioxythiophene) (PEDOT) deposi-
tion, it is possible to observe the presence of an oxidation peak
(∼0.14 V, 125 μA) and reduction peak (∼−0.14 V, ∼125 μA).
The peak separation is ∼0.24 V; this process is associated with
a quasi-reversible electrochemical process, meaning that the
process exhibits a large peak-to-peak separation compared to
reversible processes, where it is larger than 0.059/n.
Figure 1. Electrochemical readings of the sensing surfaces (MIP or NIP layers) by (a) CV and (b) EIS before the template removal. Zoomed
section represents the sensing surface before electropolymerization (PEDOT layer).
Figure 2. Electrochemical follow-up of the several modification steps of the CI-HME to produce NIP (a,c) and MIP (b,d) films by EIS (c,d,
Nyquist plots) and CV (a,b, cyclic voltammograms). Results from a solution of 5.0 mM [Fe(CN)6]
3− and 5.0 mM [Fe(CN)6]
4− in PBS buffer, pH
7.2.
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Yet, these electrical features are, by far, the best conditions
obtained with the HMEs and are similar to the electrical
features displayed by commercial screen-printed electrodes.
Consistently, EIS readings showed very little impedance values,
and no charge transfer resistance (Rct) could be extracted from
it, evidencing the high conductivity features of the system. The
results also pointed out that the applied pretreatment enabled
higher homogeneity on the surface by allowing similar results
between different batches and a better electrochemical sensor
response.
2.2. MIP Fabrication. After the previous pretreatment, the
HMEs were incubated in 4-aminothiophenol (ATP) for 1 h.
The ATP solution was an intermediate layer between PEDOT
and the subsequent OPDA layer working as a linker. The thiol
group is expected to interact with EDOT, while the amine-
aromatic ring should establish a covalent bond with the MIP/
NIP film, thereby ensuring that the imprinted polymeric layer
was securely bonded to the WE. Considering that this was a
spontaneous reaction (no external potential was applied here),
it was assumed that the thiol group would form a disulphide
bridge with some EDOT molecules on the PEDOT film
(maybe those terminating the polymeric structure). Indeed, it
was clear that a reaction occurred because the color of the
surface changes when the same reaction is tested on an
fluorine-doped tin oxde glass support. In turn, after adding
ATP, there were functional groups on the surface that could be
oxidized by CV (the aromatic amines) for further binding to
the subsequent polymeric layer, poly(oPD). Indeed, ATP was
found essential to bind steadily the two polymeric layers
because without it, the surface became unstable and the
electrode would be useless.
After the ATP incubation, the next step was the electro-
polymerization of OPDA (Figure 1). CV was the selected
technique for this process, considering the research of Gomes
et al. 201833 and several other papers in the literature using it,
even with other monomers.33 The formation of the OPDA film
introduced additional barriers to the electron-transfer proper-
ties of the redox probe. This resulted in an extra increase in the
electron-transfer resistance, reflected by a substantial rise in Rct
compared to HMEs in the previous state. The presence of Aβ-
42 on the surface of the WE, after its adsorption, was
confirmed by an Rct increase compared to the NIP HME-1
(Figure 1B). This upsurge was much more evident in the MIP,
reflecting the presence of an insulating film plus the peptide.
For the removal process, the HMEs were incubated in a
trypsin solution at 36 °C for 1 h. This step was meant to
remove the peptide from its imprinted site, leaving the
remaining polymeric network for the artificial antibody.
Trypsin is highly active and stable with low cutting specificity
and exhibits wide cleavage specificity.
After treatment with trypsin, some HMEs had unstable
electrical responses after consecutive readings, which could be
due to the adsorption of trypsin into the matrix. Thus, an extra
step was added. Another incubation was made using oxalic acid
for 2 h to ensure proper protein removal. After template
removal, the resistance decreased substantially in the MIP
(Figure 2d) and moderately in the NIP (Figure 2c). The
variation of Rct for MIP and NIP materials were Δ ≈ 30 and
13%, respectively. The higher variation in the MIP sensor is
due to the absence of the peptide in the polymeric matrix, once
the nature of the polymeric matrix is similar.
In general, this overall decrease accounted for the eventual
removal of adsorbed trypsin and small oligomeric fragments,
both in MIP and NIP films. The substantial decrease in the
MIP (Figure 2d) reflected the exit of the AD peptide from the
polymeric network.
CV assays (Figure 2a,b) were consistent with the EIS results.
The redox probe showed typical peak-to-peak potential
separation values on both devices with EDOT. The subsequent
adsorption of the protein promoted a peak decrease and a
potential shift to higher values, confirming the presence of an
additional element on the WE. After the polymerization, the
peak currents dropped to lower levels, confirming the
formation of an insulating layer on top of the HME surface.
After template removal, the peak currents recovered,
confirming the exit of the peptide from the electrode’s surface.
The NIP values showed similar behavior, except after
polymerization, where the redox peaks of the probe remained
evident.
2.3. Surface Characterization. The morphological and
chemical characterization of the biomimetic materials as well as
the control films were made through scanning electron
microscopy (SEM), Raman spectroscopy, and atomic force
microscopy (AFM) analyses.
2.3.1. Raman Spectroscopy Analysis. Raman spectra were
recorded for each different stage of construction of the sensing
film (Figure 3). In general, Raman spectra revealed the
presence of a carbon-based matrix by showing two prominent
visible peaks (D and G) at 1350 and 1580 cm−1 because all
materials relied on a carbon background. The G peak
represented the bond-stretching vibrations of sp2 hybridization
carbon atoms expressing the CC stretching; the D peak
expressed the vibrations of the carbon atoms of dangling bonds
or sp3 hybridization of carbon atoms, indicating the presence
of disordered and/or defected in the carbon. The 2D peak
represented the second order of the D band, involving a two-
phonons lattice vibrational process, without the presence of
any kind of disorder or defects.53
In general, the intensity ratio (ID/IG) is characteristic of the
extent of disorder present within the material: the higher the
ratio, the lower the disorder.54 The CI-HME was the starting
material with a ratio of 0.92. The EDOT pretreatment created
two additional peaks, the strongest one at 1442.5 cm−1 and the
other at 1506.2 cm−1, assigned to the CC stretching and
confirming the presence of PEDOT on top of the carbon
electrode.53,55,56 The addition of a polymeric imprinted layer
on the PEDOT is expected to contribute to disorder the sp2
Figure 3. Raman Spectra of CI-HME, PEDOT/CI-HME, MIP/Aβ-
42/PEDOT/CI-HME, NIP/PEDOT/CI-HME, and MIP/-/
PEDOT/CI-HME.
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carbon system, leading to higher ratio, as seen in the MIP/Aβ-
42/PEDOT/CI-HME spectrum. The increase of the ID/IG
ratio from 0.8 to 0.86 was promoted by the removal of the
peptide, indicating a higher presence of defects in the structure,
which are consistent with the template sites present in the MIP
structure. The NIP showed the lowest ratio because of the
absence of imprinted sites and therefore the lowest defects in
the structure. Overall, the surface modifications and the
presence of imprinting sites on the sensor were confirmed by
these results.
2.3.2. SEM Analysis. SEM images were collected during
several construction stages showing, in general, visible changes
in the WE for each modification. The first one, the EDOT
pretreatment displays a noticeable smooth film on the surface
(comparing to the as-produced electrodes) that not only
increased the electrode’s conductivity but also created an even
layer for the electrochemical steps further ahead (Figure
S4a,b). After polymer growth, the NIP (Figure S4c) and MIP
(Figure S4d) images look quite similar, with the MIP showing
less empty spaces, probably associated with the presence of the
peptide. After template removal, it was possible to identify
several empty spaces on the surface of the WE (Figure S4e).
2.3.3. AFM Analysis. The morphological features resulting
from each modification stage were studied on the CI-HME
surface by AFM analysis. This surface revealed to be highly
rough (Figure S5a) because the ink was deposited by
homemade approaches; so consequently, the detection of
any morphological changes promoted by single monolayer
modification was very difficult to observe. Nevertheless, it is
possible to follow the different events of the biosensor’s
construction by the different RMS (root mean square) values
of each surface modification. The electropolymerization of
EDOT on top of the carbon electrode renders a smoother film,
which is confirmed by the decrease of the RMS from 60.2 to
1.42 nm (which is in accordance with the SEM image),
allowing a superficial roughness low enough to allow the
detection of changes related to the subsequent chemical
modification (Figure S5b). The electropolymerization and
subsequent formation of the MIP (Figure S5c) rendered
significant changes in the surface roughness, which increased
up to 71.43 nm because of the addition of a 3D polymeric
monolayer onto the WE surface that grows around the
template. After the treatment with trypsin and acid, surface
roughness increased to 98.04 nm, confirming the exit of the
peptide and the presence of the template sites (Figure S5d).
With the addition of Aβ-42, these sites are no longer empty
and the surface roughness decreased to 58.48 nm (Figure S5e),
which is consistent with the calculation method employed in
RMS that calculates the arithmetic mean of the squares of a set
of numbers. Regarding the NIP formation, as expected, the
RMS is lower than that of the MIP (68.29 nm instead of 71.43
nm) because of the absence of the template.
2.4. General Analytical Features. 2.4.1. Calibration
Curves in Buffer. Some controversy still exists regarding the
amounts of Aβ-42 present in healthy and AD patients;
therefore, this work considered 23.3 pg/mL as the close value
displayed by a healthy individual.57 To test the analytical
performance of the biosensor, calibration curves were recorded
to demonstrate the ability of the proposed device to recognize
the target biomarker, relying on the high affinity recognition
cavities in the MIP materials. The analytical response was
tested in phosphate-buffered saline (PBS) buffer under similar-
to-physiological conditions, pH 7.2.
The SWV current responses were measured after each
standard concentration was allowed to bind to the sensing
layer for a fixed period of 20 min, as shown in Figure 4a. The
typical calibration curves so obtained are shown in Figure 4b,
expressing log concentration against the relative values to the
blank signal.
The oxidation/reduction current responses of the iron redox
probe in the MIP devices were inversely proportional to the
Aβ-42 concentration. In general, the peak current at 0 V
decreased with increasing concentrations of Aβ-42 diluted in
PBS. The incubation with the lowest standard solution
dropped the current values significantly, whereas the last
three exhibited a little variation of the current, pointing out a
tendency for saturation. Under optimized conditions, the MIP
exhibited a dynamic response range between 0.10 ng/mL and
1.0 μg/mL.
When compared to the MIP sensor, the NIP did not show a
linear response to the target analyte in all range of
concentrations studied, meaning that the main binding
Figure 4. SWV measurements of the (a) MIP/CI-HME-based biosensor and the corresponding calibration curve (b) and MIP (blue dots) and NIP
sensing layer (orange dots) calibration curve. Different concentrations of Aβ-42 (ng/mL) in PBS buffer. All assays were performed in 5.0 mM
[Fe(CN)6]
3− and 5.0 mM [Fe(CN)6]4− in PBS buffer, pH 7.2.
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mechanism was associated with the presence of the cavities
(positions acting as plastic antibody) within the polymeric
matrix.
2.4.2. Calibration Curves in Serum. In terms of the
background medium, the occurrence of Aβ-42 in the CSF and
its relation to AD has been established so far, but its presence
in the serum emerges now as a possible less-invasive approach.
This justifies the selection of serum to test the applicability of
this biosensor. Herein, commercial serum was used, which is a
highly complex matrix with the ability to produce valuable data
regarding the selectivity of the biosensor under conditions of
real sample analysis.
Calibration assays conducted in fetal bovine serum (FBS)
followed the same process, and the obtained results are seen in
(Figure 5).
The MIP was incubated first in serum and later in increasing
concentrations of the peptide prepared in serum. In FBS serum
samples, considering the blank incubations, no change in the
peak current happened for the first standard solution of Aβ-42
compared to the initial reading. Then, the signal decreased
with the increase in the concentration of the peptide. Under
optimized conditions, the MIP exhibited a dynamic response
range between 0.10 ng/mL and 1.0 μg/mL with LOD 0.067
ng/mL.
Overall, these results seemed promising for direct
applications in the POC context because within the
concentration range observed, the response of the MIP was
dominated by the interaction of Aβ-42 with the rebinding sites,
with negligible nonspecific response observed.
2.4.3. Selectivity Study. The study of the MIP/CI-HME
biosensor is fundamental for an effective analytical application
and was evaluated by SWV measurements. The interfering
species tested selected were based on the composition of
serum samples, such as bovine serum albumin (BSA), glucose
(Glu), and creatinine (Crea). Good selectivity was achieved
when the sensor was incubated for 20 min each with
interfering species. Each assay was conducted in a different
MIP/CI-HME in order not to avoid a cross-contamination
from the prior adsorbed interfering compound. All species
showed negligible effect on the sensory surface compared with
Aβ-42 (27%). The percentages for each interfering species was
3, 1, and 0% for BSA, glu, and Crea, respectively. Please see
Figure S6.
3. EXPERIMENTAL SECTION
3.1. Reagents and Solutions. All chemicals were of
analytical grade and used as supplied without further
purification. Milli-Q laboratory grade ultrapure water (con-
ductivity <0.1 μS/cm) was used to prepare all solutions, and all
buffer solutions were prepared in PBS (1.0 × 10−2 mol/L, pH
7.36). Potassium hexacyanoferrate III (K3[Fe(CN)6]) and
potassium hexacyanoferrate II (K4[Fe(CN)6]) trihydrate were
purchased from Riedel-de Haën; PBS was purchased from
Amresco; potassium chloride (KCl) and oxalic acid dihydrate
were purchased from Merck; ethanol absolute (99.5%) was
purchased from PanReac; EDOT 97% was purchased from
Alfa Aesar; FBS and ATP 96% were purchased from Acros
Organics; β-amyloid1−42 human (≥95%) was purchased from
GenScript; and trypsin solution 10×, OPDA, BSA, Crea, and
Glu were purchased from Sigma-Aldrich.
The electrical features of the sensing surface were followed
by checking the electrical features of a standard redox probe
composed of 5.0 × 10−3 mol/L K3[Fe(CN)6] and K4[Fe-
(CN)6] prepared in PBS buffer. A KCl solution of 0.1 mol/L
was prepared in deionized water. This solution was used as the
solvent of an EDOT solution of 0.01 mol/L. A 5.0 × 10−3
mol/L solution of ATP was prepared in a 30% ethanol aqueous
solution. OPDA standard solutions of 5.0 × 10−5 mol/L were
prepared in PBS buffer.
To prepare a control sensing layer (NIP), the polymer was
formed in the absence of the target protein. For this purpose,
an OPDA solution of 50 μmol/L was electropolymerized. The
MIP sensing layer was prepared similarly by adding 10 μL of a
solution of Aβ-42 (10 μg/mL in PBS buffer, pH 7.36) to 990
μL of the previous solution.
Calibrating solutions required the preparation of stock
solutions of Aβ-42 oligomer. These were prepared in a
concentration of 0.5 mg/mL in PBS buffer, pH 7.2. The Aβ-42
oligomer was prepared according to Gobbi et al.,58 where the
monomeric peptide solutions were diluted to 1.0 × 10−4 mol/
L in 5.0 × 10−2 mol/L phosphate buffer and 1.5 × 10−1 mol/L
NaCl, pH 7.4 and incubated for 24 h at 4 °C. Less
concentrated standards were obtained by accurate dilution of
the previous solution in PBS buffer or in Cormay Serum.
For template removal, two solutions were used: trypsin
diluted 100× in PBS buffer and oxalic acid 0.05 mol/L
prepared in deionized water.
Figure 5. SWV measurements of the (a) MIP/CI-HME-based biosensor in different concentrations of Aβ-42 (ng/mL) in Cormay Serum and the
corresponding calibration curve (b, in blue) also compared to the NIP (b, orange). All assays were performed in 5.0 mM [Fe(CN)6]
3− and 5.0 mM
[Fe(CN)6]
4− in PBS buffer, pH 7.2.
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3.2. Electrode Fabrication. For the fabrication of the
carbon electrodes, paper was the chosen novel support; but
since many types of paper exist, office paper (Navigator, 80 g/
m2, 210 × 297 mm sheets) was picked as the best match for
electrochemical sensing applications because its surface was
suitable for printing. A classical three-electrode configuration
was applied for the construction of the biosensor. Because of
this application, the paper needed to show hydrophobic
behavior, for which a wax treatment was carried out with a
Xerox ColorQube 8570 wax printer.47 After printing, hot plate
treatment was performed for 2 min at 120 °C to allow the wax
to diffuse throughout the paper thickness, rendering a
hydrophobic platform suitable for electrochemical measure-
ments.
Carbon ink (surface resistivity <30 Ω/square), obtained
from Conductive Compounds, was used to fabricate the
printed carbon electrodes. The paper-based electrochemical
devices were prepared by laminating with plastic sheets,
previously patterned with a three-electrode architecture, and
then coated with two layers of commercial carbon ink,
followed by hot plate treatment for 20 min at 120 °C. Along
its study, the electrodes were named CI-HMEs. All three
electrodes had the same ink material in the final device, shown
possible in ref 59 and used without further modification.
3.3. Biosensor Fabrication. Every assay was run in
triplicate. The first procedure in each paper-based device was
related to the reading of a blank signal (only buffer), and
analytical data was presented as relative signal to this blank.
The implemented procedures depended on the assembly of the
biosensor, described next.
3.3.1. Electrochemical Measurements and Procedures.
Electrochemical measurements were performed using a
Metrohm Autolab potentiostat/galvanostat PGSTAT320N
equipped with a FRA2 module and controlled by NOVA
1.10 software.
CV and SWV measurements were conducted in the standard
iron redox probe. For CV assays, the potential was scanned
from −0.7 to +0.7 V at 50 mV/s. For SWV studies, potentials
ranged from −0.4 to +0.3 V at a frequency of 10 Hz, with a
step height of 250 mV. EIS assays were performed with the
same redox couple solution [Fe(CN)6]3−/4− with an open
potential circuit using a sinusoidal potential perturbation with
an amplitude of 0.01 V and the number of frequencies equal to
50, logarithmically distributed over a frequency range of 0.1−
100 kHz. The impedance data was fitted with commercial
software Nova.
3.3.2. MIP Assembly. After the first readings, a pretreatment
was conducted by chronoamperometry, applying +1 V for 10 s
in the EDOT solution. Another reading was made to ensure
that the layer of PEDOT was well-formed on the WE. Then,
the device was incubated in ATP for 1 h. After this incubation
stage, electropolymerization was made by CV with either MIP
or NIP preparing solutions. The potentials were scanned from
−0.45 to +0.8 V at 100 mV/s in five consecutive cycles. The
template removal procedure was made (in both, MIP and NIP
sensing layers) by incubating the device in trypsin solution for
90 min at 36 °C, followed by another incubation in oxalic acid
for 2 h at room temperature (Figure 6).
3.3.3. Calibration Curve. The calibration curve was
performed by SWV and EIS measurements. Readings were
measured for MIP and NIP materials, with each assay
performed at least three times. Each calibration curve was
achieved after a 20 min incubation period for each Aβ-42
standard solution in increasing concentrations. Each Aβ-42
incubation was followed by an iron redox probe reading,
extracting the electrical features of the surface for each
standard concentration. The Aβ-42 concentrations ranged
from 0.1 ng/mL to 1.0 μg/mL prepared in PBS buffer.
Calibration assays were also conducted by incubating Aβ-42
standard solutions prepared in serum, followed by SWV
measurements. For this purpose, Aβ-42 was prepared in a
Cormay serum solution, diluted 100 times in the same
concentration range as before.
3.3.4. Selectivity Study. The selectivity study was performed
by incubating the interfering species in the imprinted electrode
surface for 20 min. The selected interfering species used were
BSA (0.4 mg/mL), Glu (0.7 mg/mL) and Crea (1 μg/mL)
solutions prepared in buffer.
3.4. Qualitative Characterization of the MIP Films.
The chemical/physical data of the synthetic materials was
obtained by surface and chemical analyses using Raman
spectroscopy, SEM, and AFM. The samples considered for this
study were PEDOT/CI-HME, MIP/PEDOT/CI-HME, tryp-
sin/MIP/PEDOT/CI-HME, and NIP/PEDOT/CI-HME.
Raman spectroscopy data was generated by a Thermo
Scientific DXR Raman spectroscope equipped with a confocal
microscope and a 532 nm laser. A 5 mW laser power at the
sample was allowed for 25 μm slit aperture, 60 s exposure time,
and 2 accumulations.
SEM studies were performed on a FE-Cryo SEM/EDS from
JEOL JSM 6301F, Oxford INCA Energy 350, and Gatan Alto
Figure 6. Schematic workflow for MIP production on carbon-ink electrodes prepared on a paper support. OPDA is the monomer used herein, and
Aβ-42 is the target biomarker.
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2500 microscopes operating at 15 kV and 9.9 mm working
distance.
AFM measurements were performed in an Asylum Research
MFP-3D Standalone operated in the alternate contact mode in
air (commonly known as the tapping mode) using
commercially available silicon AFM probes (Olympus
AC160TS; k = 26 N/m, f 0 = 300 kHz). The resulting
topographies were plane-fitted in Igor Pro software (Wave-
metrics), and the final images were generated using Gwyddion
software. The roughness (RMS) was automatically calculated
in Gwyddion software using the complete 2 × 2 micrometer
images. The roughness (RMS) was automatically calculated in
Gwyddion software using the complete 2 × 2 micrometer
images.
4. CONCLUSIONS
Paper-based diagnostics have been gaining importance in the
medical field, particularly regarding clinical analysis applica-
tions. Paper is the perfect material to fabricate tailor-made
miniaturized electrodes for disposable analytical tests because
it is cheap, eco-friendly, disposable, and widely available.
The present work shows a novel combination of a paper-
based electrochemical biosensor with molecular imprinting
technology for the detection of the peptide Aβ-42, which will
allow the early diagnosis of AD. The electrochemical sensor
was incorporated with a MIP because it is an alternative
approach to natural antibodies. This MIP offers many
advantages when compared to natural antibodies, considering
its high chemical stability, overall easy fabrication, and low
production costs.
Detection of amyloid-β with a MIP-based electrochemical
sensor has been reported in the literature (Moreira et al., 2017)
but neither on a paper solid substrate, with electropolymeriza-
tion of OPDA, nor with homemade carbon electrodes. The
sensor showed good operational characteristics in the range of
0.1 ng/mL to 1 μg/mL. It showed reproducibility, good
response time (around 20 min), and selectivity. As for
analytical performance, the biosensor showed adsorption of
the peptide within the desired physiologic parameters,
considering that a healthy individual shows values close to
23.3 pg/mL.
In general, the presented biosensor showed simplicity in
design and short measurement time; taking into account its
production, because it has printed carbon electrodes, it is eco-
friendly and an outstandingly inexpensive device, around 0.03€
per sensor. This promising new approach opens the doors for
the rapid and easy detection of biomarkers associated with AD
or other diseases in care settings. In the specific application of
AD, it is likely that an array of biosensors may turn out
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